Related Experiment Video
Updated: May 20, 2026
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
The mutations associated with dilated cardiomyopathy
1Department of Virology and Developmental Genetics, Faculty of Health Sciences and the National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel.
Insights
Genetic mutations cause dilated cardiomyopathy (DCM), a heart failure condition. Identifying these mutations aids in early intervention, family screening, and understanding disease mechanisms for potential therapies.
Area of Science:
- Genetics
- Cardiology
- Molecular Biology
Background:
- Cardiomyopathy is a leading cause of heart failure and a primary reason for heart transplantation.
- Dilated cardiomyopathy (DCM) is a significant subset of cardiomyopathy.
- Genetic factors play a crucial role in the etiology of DCM.
Purpose of the Study:
- To review the current genetic knowledge of dilated cardiomyopathy (DCM).
- To highlight the clinical significance of identifying causative mutations for DCM.
- To explore the relationship between identified genetic variations and disease pathogenesis.
Main Methods:
- Literature review of genetic studies on dilated cardiomyopathy.
- Analysis of identified genetic variations and their associated genes.
- Correlation of mutations with disease mechanisms and gene function.
Main Results:
- Numerous genetic variations have been identified as causative for hereditary DCM.
- These mutations impact the function of specific genes involved in cardiac muscle structure and function.
- Genetic identification enables targeted presymptomatic interventions and family screening.
Conclusions:
- Understanding the genetic basis of DCM is vital for clinical management and therapeutic development.
- Identification of disease-causing mutations offers significant benefits for affected families through genetic counseling and testing.
- Further research into gene function and pathophysiology is crucial for advancing DCM treatment strategies.
Abstract:
Cardiomyopathy is an important cause of heart failure and a major indication for heart transplantation in children and adults. This paper describes the state of the genetic knowledge of dilated cardiomyopathy (DCM). The identification of the causing mutation is important since presymptomatic interventions of DCM have proven value in preventing morbidity and mortality. Additionally, as in general in genetic studies, the identification of the mutated genes has a direct clinical impact for the families and population involved. Identifying causative mutations immediately amplifies the possibilities for disease prevention through carrier screening and prenatal testing. This often lifts a burden of social isolation from affected families, since healthy family members can be assured of having healthy children. Identification of the mutated genes holds the potential to lead to the understanding of disease etiology, pathophysiology, and therefore potential therapy. This paper presents the genetic variations, or disease-causing mutations, contributing to the pathogenesis of hereditary DCM, and tries to relate these to the functions of the mutated genes.
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
01:25Cardiomyopathy I: Introduction and Classification
01:29Cardiomyopathy V: Interprofessional Care
01:39Mutations
01:35Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...